Home | Articles
Published on:January 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(1):94-102
Original Article | doi:10.5530/ijper.56.1.12

Development and Evaluation of Nanosuspension Incorporated in situ gel of Brimonidine Tartarate for Ocular Drug Delivery


Authors and affiliation (s):

Viresh Hanagandi, Archana Sidagouda Patil*, Rajashree Shashidhar Masareddy, Panchaxari Mallappa Dandagi, Udaykumar Baburao Bolmal

Department of Pharmaceutics, KLES College of Pharmacy, Constituent Unit of KLE Academy of Higher Education and Research, Belagavi, Karnataka, INDIA.

Abstract:

Objectives: The goal of the study was to develop, optimize and in vitro-ex vivo investigation of Brimonidine tartrate nanosuspension incorporated in situ gel formulation to differentiate with marketed (formulation) eye drops for the efficient treatment of glaucoma. Materials and Methods: Nanosuspensions were formulated by solvent evaporation method using probe sonication technique. The effect of the independent variables Tween 80 and Pluronic F68 concentration on Nanosuspension properties were investigated by performing 32 factorial design of experiment. Nanosuspensions were characterized by measuring particle diameter and zeta potential, surface morphology, drug entrapment efficiency and then nanosuspensions were incorporated in to in situ gel base for in vitro release and ex-vivo corneal permeability studies and were differentiated with marketed product. Results and Discussion: The most excellent nanosuspension formulation system selected via the Design Expert 12 software program was F7 which contains 0.5% of Tween 80 and 3 % of Pluronic F68. An optimized nanosuspension formulation F7 showed an average particle diameter of 157.4±0.95 nm with PDI of 0.379 and a zeta potential of -19.1 mV. It had an average entrapment efficiency of 85.95±1.40%. It also showed 98.36±0.58% of drug being released in vitro when incorporated in to in situ gel base over 24 hr. F7 showed significantly greater drug permeation in comparison to the marketed eye drop formulation in ex vivo transcorneal permeability studies and was able of retaining its stability for 90 days. Conclusion: The developed nanosuspension incorporated in situ gel base formulation could be utilized as potential delivery system for long time management of glaucoma with once daily dose.

Key words: Brimonidine Tartrate, Ocular bioavailability, Nanosuspension, In-situ gel, Increased residence time.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2020 Journal Citation Reports® (Clarivate Analytics, 2021): 0.638

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs